Emergence of Staphylococcus aureus (MRSA) with reduced susceptibility to teicoplanin during therapy.
Weinbren
Michael
M
Struthers
Keith
K
D024881:Drug Resistance, Bacterial / Q000502:physiology; D006801:Humans; D016106:Methicillin Resistance / Q000502:physiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000302:isolation & purification / Q000502:physiology; D017334:Teicoplanin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use*
D017334:Teicoplanin